Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Hepatitis C × Ribavirin × Clear all

Phase

Phase 2 2 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hepatitis C, Chronic 3 Carcinoma, Hepatocellular 3 Respiratory Tract Infections 1 Recurrence 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Liver Diseases 1 Hepatitis C 1 Hematologic Neoplasms 1

Interventions

sofosbuvir-velpatasvir drug combination 2 ledipasvir, sofosbuvir drug combination 1 Sofosbuvir 1 Ribavirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02717949 2019-01-08

Optimal

University of Texas Southwestern Medical Center

Phase 4 Terminated

Hepatitis C, Liver Diseases, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡